CNTA · Categories · Form 3

CNTA - SEC Form 3 initial insider statements

Centessa Pharmaceuticals plc (CNTA) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for CNTA

• 310d
  New insider Accardi Mario Alberto claimed ownership of 216,485 units of Ordinary Shares (SEC Form 3)

  3 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
• 331d
  SEC Form 3 filed by new insider Deferiere Raphael

  3 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
• 469d
  SEC Form 3 filed by new insider Kanes Stephen

  3 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
• 682d
  SEC Form 3 filed by new insider Crowley John J

  3 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
• 1042d
  SEC Form 3: New insider Rotman Harris claimed ownership of 33,500 units of Ordinary Shares

  3 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
• 1242d
  SEC Form 3 filed by new insider Anderson Karen M.

  3 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
• 1394d
  SEC Form 3 filed by new insider Hukkelhoven Mathias

  3 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
• 1507d
  SEC Form 3 filed by new insider Shahidi Javad

  3 - Centessa Pharmaceuticals plc (0001847903) (Issuer)

Other CNTA categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends